Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

BACKGROUND: Several new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear. METHODS: A survey was distributed to the members of the European-African Hepato-Pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinrich, Stefan, Besselink, Marc, Moehler, Markus, van Laethem, Jean-Luc, Ducreux, Michel, Grimminger, Peter, Mittler, Jens, Lang, Hauke, Lutz, Manfred P., Lesurtel, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617881/
https://www.ncbi.nlm.nih.gov/pubmed/31288786
http://dx.doi.org/10.1186/s12885-019-5889-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617881/
https://www.ncbi.nlm.nih.gov/pubmed/31288786
http://dx.doi.org/10.1186/s12885-019-5889-5

Ejemplares similares